Literature DB >> 2991155

Analysis of HSV isolated from patients with unilateral and bilateral herpetic keratitis.

M Tognon, R Manservigi, A Sebastiani, G Bragliani, M Busin, E Cassai.   

Abstract

Restriction enzyme analysis was utilized to investigate 11 HSV isolates from patients with herpetic keratitis. The electrophoretic profiles of the DNAs indicate that the isolates belong to HSV-1 and are epidemiologically unrelated. Two of the isolates, derived from a patient with simultaneous bilateral herpetic keratitis were further characterized by genetic and phenotypic analyses. These studies showed the following: (i) the two recrudescent lesions were caused by the same HSV-1 isolate; (ii) the isolate yielded two different plaque phenotypes; (iii) these plaques showed different sensitivity to I.D.U.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2991155     DOI： 10.1007/bf00136456

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN： 0165-5701            Impact factor:   2.031


  10 in total

1.  Demonstration of exogenous genital reinfection with herpes simplex virus type 2 by restriction endonuclease fingerprinting of viral DNA.

Authors:  T G Buchman; B Roizman; A J Nahmias
Journal:  J Infect Dis       Date:  1979-09       Impact factor: 5.226

2.  A new method for the isolation of herpes simplex virus type 2 DNA.

Authors:  J M Walboomers; J T Schegget
Journal:  Virology       Date:  1976-10-01       Impact factor: 3.616

3.  9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group.

Authors:  H J Schaeffer; L Beauchamp; P de Miranda; G B Elion; D J Bauer; P Collins
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

4.  Acyclic antimetabolite therapy of experimental herpes simplex keratitis.

Authors:  D Pavan-Langston; R Campbell; J Lass
Journal:  Am J Ophthalmol       Date:  1978-11       Impact factor: 5.258

5.  Preparation of herpes simplex virus of high titer.

Authors:  B Roizman; P G Spear
Journal:  J Virol       Date:  1968-01       Impact factor: 5.103

6.  BamI, KpnI, and SalI restriction enzyme maps of the DNAs of herpes simplex virus strains Justin and F: occurrence of heterogeneities in defined regions of the viral DNA.

Authors:  H Locker; N Frenkel
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

7.  Anatomy of herpes simplex virus DNA. IX. Apparent exclusion of some parental DNA arrangements in the generation of intertypic (HSV-1 X HSV-2) recombinants.

Authors:  L S Morse; T G Buchman; B Roizman; P A Schaffer
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

8.  Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration.

Authors:  L M Collum; A Benedict-Smith; I B Hillary
Journal:  Br J Ophthalmol       Date:  1980-10       Impact factor: 4.638

9.  Molecular genetics of herpes simplex virus. VII. Characterization of a temperature-sensitive mutant produced by in vitro mutagenesis and defective in DNA synthesis and accumulation of gamma polypeptides.

Authors:  A J Conley; D M Knipe; P C Jones; B Roizman
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103
  10 in total
  6 in total

1.  Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed in human cells with a BK virus episomal vector.

Authors:  R Manservigi; M P Grossi; R Gualandri; P G Balboni; A Marchini; A Rotola; P Rimessi; D Di Luca; E Cassai; G Barbanti-Brodano
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

2.  A lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections.

Authors:  Flavia Chiuppesi; Laura Vannucci; Anna De Luca; Michele Lai; Barbara Matteoli; Giulia Freer; Roberto Manservigi; Luca Ceccherini-Nelli; Fabrizio Maggi; Mauro Bendinelli; Mauro Pistello
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

3.  High Temperature-Short Time Pasteurization Has a Lower Impact on the Antiviral Properties of Human Milk Than Holder Pasteurization.

Authors:  Manuela Donalisio; Massimo Rittà; Rachele Francese; Andrea Civra; Paola Tonetto; Alessandra Coscia; Marzia Giribaldi; Laura Cavallarin; Guido E Moro; Enrico Bertino; David Lembo
Journal:  Front Pediatr       Date:  2018-10-16       Impact factor: 3.418

4.  The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses.

Authors:  Francesco Nicoli; Valentina Finessi; Mariaconcetta Sicurella; Lara Rizzotto; Eleonora Gallerani; Federica Destro; Aurelio Cafaro; Peggy Marconi; Antonella Caputo; Barbara Ensoli; Riccardo Gavioli
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

5.  An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challenge.

Authors:  Mariaconcetta Sicurella; Francesco Nicoli; Eleonora Gallerani; Ilaria Volpi; Elena Berto; Valentina Finessi; Federica Destro; Roberto Manservigi; Aurelio Cafaro; Barbara Ensoli; Antonella Caputo; Riccardo Gavioli; Peggy C Marconi
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

6.  Acyclovir-Loaded Chitosan Nanospheres from Nano-Emulsion Templating for the Topical Treatment of Herpesviruses Infections.

Authors:  Manuela Donalisio; Federica Leone; Andrea Civra; Rita Spagnolo; Ozgen Ozer; David Lembo; Roberta Cavalli
Journal:  Pharmaceutics       Date:  2018-04-10       Impact factor: 6.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.